Clinical Trial Update: Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating a single intravitreal injection of human retinal progenitor cells (jCell) for retinitis pigmentosa has completed with post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• jCell (human retinal progenitor cells)

Snippet

Sponsor: jCyte, Inc | Conditions: Retinitis Pigmentosa (RP) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-05